Uni Eropa - Inggris - EMA (European Medicines Agency)

cis bio international - ioflupane (123l) - radionuclide imaging; dementia; movement disorders - diagnostic radiopharmaceuticals - this medicinal product is for diagnostic use only.striascan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. striascan is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy.in adult patients, to help differentiate probable dementia with lewy bodies from alzheimer’s disease. striascan is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - cisplatin 1 mg/ml - solution for injection - 1 mg/ml - active: cisplatin 1 mg/ml excipient: hydrochloric acid sodium chloride water for injection - cisplatin ebewe is indicated as palliative therapy to be employed as follows: metastatic non-seminomatous germ cell carcinoma: in established combination therapy with other approved chemotherapeutic agents in patients with metastatic non-seminomatous germ cell tumours who have already received appropriate surgical and/or radiotherapeutic procedures. metastatic ovarian tumours: cisplatin ebewe, as a single agent, is indicated as secondary therapy in patients with metastatic ovarian tumours refractory to standard chemotherapy who have not previously received cisplatin ebewe therapy. advanced and refractory carcinoma of the bladder: cisplatin ebewe, as a single agent, is indicated as secondary therapy in patients with advanced stage bladder cancer refractory to standard chemotherapy who have not previously received cisplatin ebewe therapy. squamous cell carcinoma of the head and neck (refractory to standard chemotherapy): cisplatin ebewe, as a single agent, is indicated as secondary therapy in patients with squamous cell carcinoma of the head and neck refractory to standard chemotherapy who have not previously received cisplatin ebewe therapy.

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

cis bio international - calcium trisodium pentetate - powder for solution for injection - 9.10 mg milligram - technetium (99mtc) compounds; technetium (99mtc) pentetic acid

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

cis bio international - sodium oxidronate - kit for radiopharmaceutical preparation - 3.0 milligram(s) - technetium (99mtc) compounds; technetium (99mtc) oxidronic acid

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - cisplatin 1 mg/ml;   - solution for injection - 1 mg/ml - active: cisplatin 1 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - cisplatin accord injection is indicated for the palliative treatment of: · metastatic non-seminomatous germ cell carcinoma; · advanced-stage refractory ovarian carcinoma; · advanced-stage refractory bladder carcinoma; and · refractory squamous cell carcinoma of the head and neck. it may be used as a single agent or in combination with other chemotherapeutic agents. it may be employed, in appropriate circumstances, in addition to other modalities, e.g. radiotherapy or surgery.

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

cis bio international - fluorodopa (18 f) - solution for injection - 90 mbq/ml - other diagnostic radiopharmaceuticals for tumour detection

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

cis bio international - rhenium sulphide - kit for radiopharmaceutical preparation - milligram - technetium (99mtc), particles and colloids

Malta - Inggris - Malta Medicines Authority

cis bio international route nationale 306-saclay, bp 32, 91192, gif-sur-yvette cedex, france - fluorodopa - solution for injection - fluorodopa (18f) 90 mbq/ml - diagnostic radiopharmaceuticals

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

cis bio international - dimercaptosuccinic acid - kit for radiopharmaceutical preparation - 1 mg - technetium (99mtc) compounds; technetium (99mtc) succimer

Irlandia - Inggris - HPRA (Health Products Regulatory Authority)

cis bio international - tetrakis (2-methoxy isobutyl isonitrile) copper (i) tetrafluorolborate - kit for radiopharmaceutical preparation - 1 milligram(s) - technetium (99mtc) compounds; technetium (99mtc) sestamibi